Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Type I IFN ineffectively activates neonatal dendritic cells limiting respiratory antiviral T-cell responses.

Lau-Kilby AW, Turfkruyer M, Kehl M, Yang L, Buchholz UJ, Hickey K, Malloy AMW.

Mucosal Immunol. 2019 Dec 4. doi: 10.1038/s41385-019-0234-5. [Epub ahead of print]

PMID:
31797910
2.

Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.

McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, Thumar B, Gnanashanmugam D, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Spector SA, Aziz M, Cielo M, Beneri C, Wiznia A, Luongo C, Collins P, Buchholz U; and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) 2011 Study Team.

J Infect Dis. 2019 Nov 23. pii: jiz603. doi: 10.1093/infdis/jiz603. [Epub ahead of print]

PMID:
31758177
3.

Optimization of the codon-pair usage of human respiratory syncytial virus paradoxically resulted in reduced viral replication in vivo and reduced immunogenicity.

Le Nouën C, Luongo CL, Yang L, Mueller S, Wimmer E, DiNapoli JM, Collins PL, Buchholz UJ.

J Virol. 2019 Oct 30. pii: JVI.01296-19. doi: 10.1128/JVI.01296-19. [Epub ahead of print]

4.

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children.

Karron RA, Luongo C, Mateo JS, Wanionek K, Collins PL, Buchholz UJ.

J Infect Dis. 2019 Oct 12. pii: jiz408. doi: 10.1093/infdis/jiz408. [Epub ahead of print]

PMID:
31605113
5.

Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.

Le Nouën C, Hillyer P, Levenson E, Martens C, Rabin RL, Collins PL, Buchholz UJ.

J Virol. 2019 Oct 29;93(22). pii: e01216-19. doi: 10.1128/JVI.01216-19. Print 2019 Nov 15.

6.

The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.

Lingemann M, McCarty T, Liu X, Buchholz UJ, Surman S, Martin SE, Collins PL, Munir S.

PLoS Pathog. 2019 Aug 5;15(8):e1007963. doi: 10.1371/journal.ppat.1007963. eCollection 2019 Aug.

7.

Estimation of influenza- and respiratory syncytial virus-attributable medically attended acute respiratory infections in Germany, 2010/11-2017/18.

An der Heiden M, Buchholz U, Buda S.

Influenza Other Respir Viruses. 2019 Jul 24. doi: 10.1111/irv.12666. [Epub ahead of print]

8.

Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding.

Le Nouën C, Collins PL, Buchholz UJ.

Front Immunol. 2019 Jun 4;10:1250. doi: 10.3389/fimmu.2019.01250. eCollection 2019. Review.

9.

Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated.

Cunningham CK, Karron R, Muresan P, McFarland EJ, Perlowski C, Libous J, Thumar B, Gnanashanmugam D, Moye J Jr, Schappell E, Barr E, Rexroad V, Aziz M, Deville J, Rutstein R, Yang L, Luongo C, Collins P, Buchholz U; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) 2012 Study Team.

Open Forum Infect Dis. 2019 May 6;6(6):ofz212. doi: 10.1093/ofid/ofz212. eCollection 2019 Jun.

10.

Taxonomy of the order Mononegavirales: update 2019.

Amarasinghe GK, Ayllón MA, Bào Y, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chabi-Jesus C, Chandran K, Chiapponi C, Crozier I, de Swart RL, Dietzgen RG, Dolnik O, Drexler JF, Dürrwald R, Dundon WG, Duprex WP, Dye JM, Easton AJ, Fooks AR, Formenty PBH, Fouchier RAM, Freitas-Astúa J, Griffiths A, Hewson R, Horie M, Hyndman TH, Jiāng D, Kitajima EW, Kobinger GP, Kondō H, Kurath G, Kuzmin IV, Lamb RA, Lavazza A, Lee B, Lelli D, Leroy EM, Lǐ J, Maes P, Marzano SL, Moreno A, Mühlberger E, Netesov SV, Nowotny N, Nylund A, Økland AL, Palacios G, Pályi B, Pawęska JT, Payne SL, Prosperi A, Ramos-González PL, Rima BK, Rota P, Rubbenstroth D, Shī M, Simmonds P, Smither SJ, Sozzi E, Spann K, Stenglein MD, Stone DM, Takada A, Tesh RB, Tomonaga K, Tordo N, Towner JS, van den Hoogen B, Vasilakis N, Wahl V, Walker PJ, Wang LF, Whitfield AE, Williams JV, Zerbini FM, Zhāng T, Zhang YZ, Kuhn JH.

Arch Virol. 2019 Jul;164(7):1967-1980. doi: 10.1007/s00705-019-04247-4.

PMID:
31089958
11.

Feasibility study for the use of self-collected nasal swabs to identify pathogens among participants of a population-based surveillance system for acute respiratory infections (GrippeWeb-Plus)-Germany, 2016.

Haussig JM, Targosz A, Engelhart S, Herzhoff M, Prahm K, Buda S, Nitsche A, Haas W, Buchholz U.

Influenza Other Respir Viruses. 2019 Jul;13(4):319-330. doi: 10.1111/irv.12644. Epub 2019 Mar 29.

12.

[Estimation of heat-related deaths in Germany between 2001 and 2015].

An der Heiden M, Muthers S, Niemann H, Buchholz U, Grabenhenrich L, Matzarakis A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 May;62(5):571-579. doi: 10.1007/s00103-019-02932-y. Review. German.

PMID:
30923846
13.

Taxonomy of the order Mononegavirales: second update 2018.

Maes P, Amarasinghe GK, Ayllón MA, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chandran K, Crozier I, de Swart RL, Dietzgen RG, Dolnik O, Domier LL, Drexler JF, Dürrwald R, Dundon WG, Duprex WP, Dye JM, Easton AJ, Fooks AR, Formenty PBH, Fouchier RAM, Freitas-Astúa J, Ghedin E, Griffiths A, Hewson R, Horie M, Hurwitz JL, Hyndman TH, Jiāng D, Kobinger GP, Kondō H, Kurath G, Kuzmin IV, Lamb RA, Lee B, Leroy EM, Lǐ J, Marzano SL, Mühlberger E, Netesov SV, Nowotny N, Palacios G, Pályi B, Pawęska JT, Payne SL, Rima BK, Rota P, Rubbenstroth D, Simmonds P, Smither SJ, Song Q, Song T, Spann K, Stenglein MD, Stone DM, Takada A, Tesh RB, Tomonaga K, Tordo N, Towner JS, van den Hoogen B, Vasilakis N, Wahl V, Walker PJ, Wang D, Wang LF, Whitfield AE, Williams JV, Yè G, Zerbini FM, Zhang YZ, Kuhn JH.

Arch Virol. 2019 Apr;164(4):1233-1244. doi: 10.1007/s00705-018-04126-4.

PMID:
30663023
14.

Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.

Liang B, Kabatova B, Kabat J, Dorward DW, Liu X, Surman S, Liu X, Moseman AP, Buchholz UJ, Collins PL, Munir S.

J Virol. 2019 Mar 21;93(7). pii: e02043-18. doi: 10.1128/JVI.02043-18. Print 2019 Apr 1.

15.

Probable reinfection with Legionella pneumophila - A case report.

Buchholz U, Reber F, Lehfeld AS, Brodhun B, Haas W, Schaefer B, Stemmler F, Otto C, Gagell C, Lück C, Gamradt R, Heinig M, Meisel C, Kölsch U, Eisenblätter M, Jahn HJ.

Int J Hyg Environ Health. 2019 Mar;222(2):315-318. doi: 10.1016/j.ijheh.2018.11.001. Epub 2018 Nov 27.

PMID:
30501994
16.

Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.

Brock LG, Liu X, Liang B, Lingemann M, Liu X, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S.

J Virol. 2018 Aug 16;92(17). pii: e00723-18. doi: 10.1128/JVI.00723-18. Print 2018 Sep 1.

17.

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, Buchholz UJ, Openshaw PJ, McLellan JS, Englund JA, Mejias A, Karron RA, Simões EA, Knezevic I, Ramilo O, Piedra PA, Chu HY, Falsey AR, Nair H, Kragten-Tabatabaie L, Greenough A, Baraldi E, Papadopoulos NG, Vekemans J, Polack FP, Powell M, Satav A, Walsh EE, Stein RT, Graham BS, Bont LJ; Respiratory Syncytial Virus Network (ReSViNET) Foundation.

Lancet Infect Dis. 2018 Oct;18(10):e295-e311. doi: 10.1016/S1473-3099(18)30292-5. Epub 2018 Jun 18. Review. Erratum in: Lancet Infect Dis. 2018 Jul 25;:.

18.

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Hillyer P, Shepard R, Uehling M, Krenz M, Sheikh F, Thayer KR, Huang L, Yan L, Panda D, Luongo C, Buchholz UJ, Collins PL, Donnelly RP, Rabin RL.

J Virol. 2018 Jul 17;92(15). pii: e02202-17. doi: 10.1128/JVI.02202-17. Print 2018 Aug 1.

19.

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.

Buchholz UJ, Cunningham CK, Muresan P, Gnanashanmugam D, Sato P, Siberry GK, Rexroad V, Valentine M, Perlowski C, Schappell E, Thumar B, Luongo C, Barr E, Aziz M, Yogev R, Spector SA, Collins PL, McFarland EJ, Karron RA; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1114 Study Team.

J Infect Dis. 2018 Apr 11;217(9):1338-1346. doi: 10.1093/infdis/jiy066.

20.

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.

McFarland EJ, Karron RA, Muresan P, Cunningham CK, Valentine ME, Perlowski C, Thumar B, Gnanashanmugam D, Siberry GK, Schappell E, Barr E, Rexroad V, Yogev R, Spector SA, Aziz M, Patel N, Cielo M, Luongo C, Collins PL, Buchholz UJ; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) 2000 Study Team.

J Infect Dis. 2018 Apr 11;217(9):1347-1355. doi: 10.1093/infdis/jiy040.

21.

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS; Global Seasonal Influenza-associated Mortality Collaborator Network.

Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14. Erratum in: Lancet. 2018 Jan 19;:.

22.

Multicolor Stimulated Emission Depletion (STED) Microscopy to Generate High-resolution Images of Respiratory Syncytial Virus Particles and Infected Cells.

Mehedi M, Smelkinson M, Kabat J, Ganesan S, Collins PL, Buchholz UJ.

Bio Protoc. 2017 Sep 5;7(17). pii: e2543. doi: 10.21769/BioProtoc.2543.

23.

A novel host factor for human respiratory syncytial virus.

Mehedi M, Collins PL, Buchholz UJ.

Commun Integr Biol. 2017 May 8;10(3):e1319025. doi: 10.1080/19420889.2017.1319025. eCollection 2017.

24.

Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children.

Karron RA, San Mateo J, Wanionek K, Collins PL, Buchholz UJ.

J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):86-89. doi: 10.1093/jpids/pix006.

25.

Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.

Weidemann F, Remschmidt C, Buda S, Buchholz U, Ultsch B, Wichmann O.

BMC Infect Dis. 2017 Apr 11;17(1):258. doi: 10.1186/s12879-017-2344-6.

26.

Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.

Lingemann M, Liu X, Surman S, Liang B, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S.

J Virol. 2017 Apr 28;91(10). pii: e02469-16. doi: 10.1128/JVI.02469-16. Print 2017 May 15.

27.

Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Hillyer P, Mane VP, Chen A, Dos Santos MB, Schramm LM, Shepard RE, Luongo C, Le Nouën C, Huang L, Yan L, Buchholz UJ, Jubin RG, Collins PL, Rabin RL.

Virology. 2017 Apr;504:63-72. doi: 10.1016/j.virol.2017.01.017. Epub 2017 Jan 31.

28.

Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.

Le Nouën C, McCarty T, Brown M, Smith ML, Lleras R, Dolan MA, Mehedi M, Yang L, Luongo C, Liang B, Munir S, DiNapoli JM, Mueller S, Wimmer E, Collins PL, Buchholz UJ.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E386-E395. doi: 10.1073/pnas.1619242114. Epub 2017 Jan 3.

29.

Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread.

Mehedi M, McCarty T, Martin SE, Le Nouën C, Buehler E, Chen YC, Smelkinson M, Ganesan S, Fischer ER, Brock LG, Liang B, Munir S, Collins PL, Buchholz UJ.

PLoS Pathog. 2016 Dec 7;12(12):e1006062. doi: 10.1371/journal.ppat.1006062. eCollection 2016 Dec.

30.

Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.

An der Heiden M, Buchholz U.

Influenza Other Respir Viruses. 2017 Mar;11(2):110-121. doi: 10.1111/irv.12434. Epub 2016 Nov 18.

31.

Human metapneumovirus Induces Reorganization of the Actin Cytoskeleton for Direct Cell-to-Cell Spread.

El Najjar F, Cifuentes-Muñoz N, Chen J, Zhu H, Buchholz UJ, Moncman CL, Dutch RE.

PLoS Pathog. 2016 Sep 28;12(9):e1005922. doi: 10.1371/journal.ppat.1005922. eCollection 2016 Sep.

32.

I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?

Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, Cohen JM, Oroszi B, Rizzo C, Machado A, Pitigoi D, Domegan L, Paradowska-Stankiewicz I, Buchholz U, Gherasim A, Daviaud I, Horváth JK, Bella A, Lupulescu E, O Donnell J, Korczyńska M, Moren A; I-MOVE case–control study team.

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30201.

33.

[Influenza pandemic deaths in Germany from 1918 to 2009. Estimates based on literature and own calculations].

Buchholz U, Buda S, Reuß A, Haas W, Uphoff H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):523-36. doi: 10.1007/s00103-016-2324-9. Review. German.

PMID:
26984565
34.

Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children.

Karron RA, San Mateo J, Thumar B, Schaap-Nutt A, Buchholz UJ, Schmidt AC, Bartlett EJ, Murphy BR, Collins PL.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):e143-6. doi: 10.1093/jpids/piu104. Epub 2014 Nov 12.

35.

A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children.

Karron RA, Luongo C, Thumar B, Loehr KM, Englund JA, Collins PL, Buchholz UJ.

Sci Transl Med. 2015 Nov 4;7(312):312ra175. doi: 10.1126/scitranslmed.aac8463.

36.

Low-level Circulation of Enterovirus D68-Associated Acute Respiratory Infections, Germany, 2014.

Reiche J, Böttcher S, Diedrich S, Buchholz U, Buda S, Haas W, Schweiger B, Wolff T.

Emerg Infect Dis. 2015 May;21(5):837-41. doi: 10.3201/eid2105.141900.

37.

TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization.

Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, Rodriguez A, Reynaldi A, Garcia A, Bado D, Buchholz UJ, Hijano DR, Coviello S, Newcomb D, Bellabarba M, Ferolla FM, Libster R, Berenstein A, Siniawaski S, Blumetti V, Echavarria M, Pinto L, Lawrence A, Ossorio MF, Grosman A, Mateu CG, Bayle C, Dericco A, Pellegrini M, Igarza I, Repetto HA, Grimaldi LA, Gudapati P, Polack NR, Althabe F, Shi M, Ferrero F, Bergel E, Stein RT, Peebles RS, Boothby M, Kleeberger SR, Polack FP.

J Clin Invest. 2015 Feb;125(2):571-82. doi: 10.1172/JCI75183. Epub 2015 Jan 2.

38.

Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.

Le Nouën C, Brock LG, Luongo C, McCarty T, Yang L, Mehedi M, Wimmer E, Mueller S, Collins PL, Buchholz UJ, DiNapoli JM.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13169-74. doi: 10.1073/pnas.1411290111. Epub 2014 Aug 25.

39.

A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection.

Dave KA, Norris EL, Bukreyev AA, Headlam MJ, Buchholz UJ, Singh T, Collins PL, Gorman JJ.

Mol Cell Proteomics. 2014 Dec;13(12):3250-69. doi: 10.1074/mcp.M114.041129. Epub 2014 Aug 8.

40.

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

Liesman RM, Buchholz UJ, Luongo CL, Yang L, Proia AD, DeVincenzo JP, Collins PL, Pickles RJ.

J Clin Invest. 2014 May;124(5):2219-33. doi: 10.1172/JCI72948. Epub 2014 Apr 8.

41.

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.

Taylor G, Wyld S, Valarcher JF, Guzman E, Thom M, Widdison S, Buchholz UJ.

J Gen Virol. 2014 Jun;95(Pt 6):1244-54. doi: 10.1099/vir.0.064931-0. Epub 2014 Apr 3.

42.

Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Le Nouën C, Hillyer P, Brock LG, Winter CC, Rabin RL, Collins PL, Buchholz UJ.

J Virol. 2014 Jun;88(11):6453-69. doi: 10.1128/JVI.03261-13. Epub 2014 Mar 26.

43.

Contact investigation for imported case of Middle East respiratory syndrome, Germany.

Reuss A, Litterst A, Drosten C, Seilmaier M, Böhmer M, Graf P, Gold H, Wendtner CM, Zanuzdana A, Schaade L, Haas W, Buchholz U.

Emerg Infect Dis. 2014 Apr;20(4):620-5. doi: 10.3201/eid2004.131375.

44.

Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.

Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, Rogalska J, Pitigoi D, Paradowska-Stankiewicz I, Reuss A, Jiménez-Jorge S, Daviaud I, Guiomar R, O'Donnell J, Necula G, Głuchowska M, Moren A.

Euro Surveill. 2014 Feb 13;19(6). pii: 20701.

45.

Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35/2011 to 34/2012.

Bayer C, Remschmidt C, an der Heiden M, Tolksdorf K, Herzhoff M, Kaersten S, Buda S, Haas W, Buchholz U.

Euro Surveill. 2014 Jan 30;19(4). pii: 20684. No abstract available.

46.

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.

Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.

J Virol. 2014 Apr;88(8):4237-50. doi: 10.1128/JVI.03481-13. Epub 2014 Jan 29.

47.

Live-attenuated respiratory syncytial virus vaccines.

Karron RA, Buchholz UJ, Collins PL.

Curr Top Microbiol Immunol. 2013;372:259-84. doi: 10.1007/978-3-642-38919-1_13.

48.

[Informations and recommendations of the German Respiratory Society and the Paul-Ehrlich-Society for chemotherapy concerning the outbreak of influenza A(H7N9) virus infections in humans].

Höffken G, Kern P, Buchholz U, Ewig S, Schaberg T.

Pneumologie. 2013 Nov;67(11):599-604. doi: 10.1055/s-0033-1344807. Epub 2013 Oct 23. German.

49.

Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques.

Khattar SK, Nayak B, Kim SH, Xiao S, Samal S, Paldurai A, Buchholz UJ, Collins PL, Samal SK.

PLoS One. 2013 Oct 10;8(10):e75456. doi: 10.1371/journal.pone.0075456. eCollection 2013.

50.

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.

Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group.

Vaccine. 2013 Nov 19;31(48):5706-12. doi: 10.1016/j.vaccine.2013.09.046. Epub 2013 Oct 5.

Supplemental Content

Loading ...
Support Center